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RESUMEN
Las biocerámicas basadas en fosfato cálcico presentan un 
elevado potencial para su aplicación en la regeneración 
ósea gracias a su similitud con la estructura química de 
la biocerámica presente en los huesos y dientes de los 
mamíferos. Su utilización constituye una alternativa viable 
a la del uso de trasplantes autólogos u alografos para el 
tratamiento de enfermedades óseas. Este trabajo estudia 
la bioactividad de diferentes sustitutos óseos comercia-
les basados en fosfato cálcico, mediante la medida de su 
capacidad de intercambio iónico al sumergirlos en fluido 
corporal simulado (SBF, en inglés simulated body fluid).  
Palabras clave: Regeneración ósea, biocerámica, bioacti-
vidad, intercambio iónico, polimerización por plasma
SUMMARY
Calcium phosphate-based bioceramics constitute a great 
promise for bone tissue engineering as they chemically re-
semble to mammalian bone and teeth. Their use is a via-
ble alternative for bone regeneration as it avoids the use of 
autografts and allografts, which usually involves immuno-
genic reactions and patient’s discomfort. This work evolves 
around the study of the bioactivity potential of different com-
mercially available bone substitutes based in calcium phos-
phate through the characterization of their ionic exchange 
ability when immersed in simulated body fluid (SBF).  
Keywords: Bone regeneration, bioceramics, bioactivity, 
ionic exchange, plasma polymerization
RESUM
Les bioceràmiques basades en fosfat càlcic presenten un 
elevat potencial per a la seva aplicació en la regeneració 
òssia gràcies a la seva similitud amb l’estructura química 
de la bioceràmica present en els ossos i dents dels mamí-
fers. La seva utilització és una alternativa viable a la de l’ús 
de trasplantaments autòlegs o al·loempelts per al tracta-
ment de malalties òssies. Aquest treball estudia la bioac-
tivitat, de diferents substituts ossis comercials basats en 
fosfat càlcic, mitjançant la mesura de la seva capacitat 
d’intercanvi iònic al submergir-los en fluid corporal simulat 
(SBF, en anglès simulated body fluid).
Paraules clau:  regeneració òssia, bioceràmica, bioactivi-
tat intercanvi iònic, polimerització per plasma.
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INTRODUCTION
Nowadays, autografts (a patient’s own bone) remain the 
gold standard for bone repair followed by allografts (bone 
from another subject of the same species). Autografts and 
allografts have major advantages such being osteogenic 
or osteoinductive, however they present several disadvan-
tages. As for the autografts, harvesting the tissue requires 
another second surgical practice, with well documented 
complications and discomfort for the patient1. Moreover, it 
must be taken into account that the quantity of tissue that 
can be extracted is limited. Allogeneic bone-grafting cons-
titutes an alternative to autografts, as it overcomes the 
problem with harvesting and quantity, however, it presents 
issues of immunogenicity and rejection reactions and pos-
sibility of infection transmission2. Thus, there is the need 
for developing synthetic alternative materials to overcome 
the limitations of both autografts and allografts.
Among all the synthetic biomaterials for bone regenera-
tion, calcium phosphate bioceramics are those which 
chemically resemble more to the mammalian bones and 
teeth3. Table 1. Calcium orthophosphates main fea-
tures4presents the solubility product constants (Ksp) of 
the most commonly used calcium orthophosphates in bio-
medical applications, among others. 
Table 1. Calcium orthophosphates main features4
Ca/P 
molar 
ratio
Compound Formula
-log (Ksp ) at 
25ºC
-log (Ksp ) at 
37ºC
1
Dicalcium phos-
phate (DCP) CaHPO4 6,9 7,02
1,33
Octacalcium 
phosphate (OCP) Ca8H2(PO4)6·5H2O 96,6 95,9
1,5
b-tricalcium phos-
phate (a-TCP) b-Ca3(PO4)2 25,5 25,5
1,5
b-tricalcium phos-
phate (b-TCP) b-Ca3(PO4)3(OH) 28,9 29,5
1,67 Hydroxyapatite (HA) Ca5(PO4)3(OH) 58,4 58,6
2
Tetracalcium 
phosphate (TTCP) Ca4(PO4)2O 38-44 42,4
It is important to mention that only those compounds 
which present a Ca/P molar ratio higher than 1 are suit-
able for biomedical applications, since a Ca/P ratio less 
than 1 implies a high solubility and acidity when implant-
ed into the body5. The majority of available bioceramics 
are based on HA, b-TCP, a-TCP and/or biphasic cal-
cium phosphate (BCP) which is an intimate mixture of 
b-TCP+HA or a-TCP+HA. Hydroxyapatite, compared to 
a-TCP and b-TCP, presents a higher stability under phys-
iological conditions as it has a lower solubility and thus, 
a lower resorption rate by the surrounding bone tissue. 
Therefore, BCP formulations aim to present the optimum 
balance between a more stable HA phase and a more 
soluble TCP for a specific application. It must be noticed 
that an increase of TCP/HA ratio increases BCP reactivity, 
thus its in vivo bioresorbability can be controlled through 
the phase composition6. The control of the bioresorbabil-
ity of the bone graft is critical, as the dissolution of the 
bioresorbable material allows the newly formed tissue to 
grow into the defect site. Thus, bioresorbable materials 
are able to participate in dynamic processes of formation 
and resorption occurring in bone tissues and hence they 
constitute a good option to be used as scaffolds or filling 
spacers allowing their infiltration and substitution of the tis-
sues7.                                                                                                                                                   
Back in 1990 Kokubo et al. reported for the first time the 
use of SBF in order to assess the bone-like apatite forma-
tion onto a bioactive glass ceramic8. Based on their results, 
in 1991, they proposed that the essential requirement for 
a material to bond to living bone is the formation of bone-
like apatite on its surface when implanted in the living body 
and that this in vivo apatite formation can be reproduced 
in SBF9however, had explained the bone-bonding mech-
anism of Ceravital-type apatite-containing glass-ceramic 
without mentioning formation of the surface apatite layer. 
In the present study, apatite formation on the surface of 
one of Ceravital-type glass-ceramics was investigated in 
vitro as well as in vivo. An apatite-containing glass-ceram-
ic of the composition Na2O 5, CaO 33, SiO2 46, Ca(PO3. 
Since then, numerous studies have been published which 
use SBF to evaluate bioactivity10,11. 
This study focuses on the bioactivity study of calcium 
phosphate-based bone substitute materials that can be 
used for bone regeneration in dental and medical appli-
cations. To do so, based on previous results10,11, we have 
measured their ionic exchange ability with SBF. Moreover, 
we have evaluated the effect of the presence of a pen-
tafluorophenyl methacrylate (PFM) coating over the ionic 
exchange ability of a commercial hydroxyapatite. 
The interest of using PFM coatings arises from its ability to 
react with amines through a highly reactive ester group12,13, 
which constitutes a mechanism to anchor cell-signaling 
biomolecules (Figure 2) enabling the bone substitute to 
induce a desired cell behavior. 
MATERIALS AND METHODS
Five commercial calcium phosphate based-bone substi-
tutes have been analyzed. Table 2 summarizes their prop-
erties, the main difference being the composition, shape 
and particle size.. 
Table 2. Main specifications of the studied bone substitutes
Sample Particle Size (mm) Composition
Sample 1 150-500 b-TCP
Sample 2 0,25-1 Bovine HA
Sample 3 500 - 1000 HA/b-TCP (60:40)
Sample 4 -- HA
X-Ray Diffraction (XRD)
Prior to XRD analysis the five samples were grinded into 
powder. The phase analysis of the HA powders was carried 
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out employing an X-Ray diffractometer (Bruker D-5005) 
using a Cu Ka radiation generated at 40kV and 100 mA.
Bone substitutes interaction with physiologic media
The interaction of the hydroxyapatite – based bone subs-
titutes with physiologic media was determined by soaking 
the samples in the interest solutions. In analyzed bone 
substitutes were in form of granules or powder. Using a 
hydraulic press (10 tones), they were compacted into discs 
of about 13 mm of diameter and 1,5 mm of height.
The hydroxyapatite discs were immersed at 37ºC into si-
mulated body fluid (SBF), which was prepared by dissol-
ving the following compounds into 500 ml of Milli-Q water, 
and adjusting the pH with 3.029 g of tris-hydroxymethyla-
minomethane and HCl to 7.4: 3.273 g of NaCl, 1.134 g of 
NaHCO3, 0.186 g KCl, 0.0339 g of Na2HPO4·12 H2O, 0.152 
g of MgCl2·6H2O, 0.184 g of CaCl2·2H2O and 0.036 g of 
Na2SO4. 
pH and calcium concentration measurements were per-
formed at different time points in order to assess the ionic 
exchange ability of the samples. Changes in calcium con-
centration were determined by atomic absorption spec-
troscopy 
Atomic absorption spectroscopy (AAS)
Calcium concentration was determined using a 2280 Ato-
mic Absorption Spectrophotometer (Perkin – Elmer). Cali-
bration of the instrument was performed using 0.5, 1, 2.5 
and 5 ppm calcium carbonate standard solutions. In order 
to avoid interferences, both the standards and the sam-
ples had to be mixed with lanthanum oxide (La2O3). The 
La2O3 stock solution was prepared by mixing 5.865g of the 
oxide, 50 ml of Milli-Q water and 254 ml of HCl(c) and pos-
terior dilution up to 100 ml in a volumetric flask. The sam-
ples and standards where mixed with La2O3 maintaining a 
ratio of 1:2 respectively.
Hydroxyapatite surface modification by PECVD
Before performing the superficial modification the sam-
ples were compacted into disks using a hydraulic press 
following the procedure described above. The hydroxya-
patite surface was modified with a coating of Pentafluo-
rophenyl methacrylate (PFM, 95% Sigma-Aldrich) using 
a cold plasma reactor at low pressure15. Briefly, the mo-
nomer (PFM) is introduced inside the reactor at nearly 
constant pressure around 0,02-0,04 mbar. Once pressure 
is stable the continuous radio frequency power is fixed at 
15W and a pulsed plasma polymerization duty cycle (DC) 
of 10/20 is carried out during 5 minutes. 
RESULTS AND DISCUSSION
Soaking the bioceramic bone substitutes with physio-
logic media
Among all the SBF that have been formulated, we have 
used the one described by Takadama et al. in 200416. 
Table 3. Comparison of ions concentration between 
blood plasma and SBFshows a comparison between the 
ionic concentrations of blood plasma and SBF. 
Table 3. Comparison of ions concentra-
tion between blood plasma and SBF
Ion concentra-
tion / mM Na
+ K+ Ca2+ Mg2+ HCO3
- Cl- HPO4
2- SO4
2-
Blood Plasma 142.0 5.0 2.5 1.5 27.0 147.8 1.0 0.5
SBF 142.0 5.0 2.5 1.5 4.2 103.0 1.0 0.5
When the samples were soaked into SBF, all solutions un-
derwent changes in pH and calcium concentration. As it can 
be seen in Figure 1 both the pH and [Ca2+] evolution profile 
Figure 2. Calcium phosphate-based samples ionic exchange ability (A) pH evolution of SBF solution during sample’s im-
mersion period. (B) pH value of SBF solution after 24 hours of soaking. (C) Calcium concentration at SBF solution evo-
lution during sample’s immersion period. (D) Calcium concentration at SBF solution after 24 hours of soaking.
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is very similar for all the samples. It must be noticed how 
every change of pH occurs simultaneously with a change of 
[Ca2+], thus, we can be certain that the measured pH chang-
es are due to the interaction between the immersed calcium 
phosphate disk and the surrounding medium. In order to 
make comparisons between the studied samples, we will 
use the pH evolution profile, as it reflects all the events that 
are taking place during the ionic exchange. 
The initial dissolution of b-TCP and HA causes an increase in 
both calcium concentration and pH. In agreement with pre-
vious studies11,17, we hypothesize that due to the dissolution 
of b-TCP and HA, there is an initial release of calcium ions to 
the SBF solution, reflected by an increase of pH caused by 
the absorption of H3O
+ from the solution. Following the initial 
increase, SBF pH value seems to stabilize, however, a third 
phase in which the pH decreases, can be distinguished. It 
can be explained considering that the latter is caused by the 
precipitation of HA or b-TCP, which leads to an absorption 
of both OH- and HPO3- ions from the solution to the sam-
ple disk. As it is shown in Table 1, b-TCP presents a higher 
solubility than HA at 37ºC, so one may think that the initial 
dissolution would take place faster for sample 1, which is 
composed of pure b-TCP. However, as said before, the de-
gree of crystallinity has a strong relation with the ionic ex-
change ability of the sample. A higher degree of crystallinity 
can be associated with a higher thermodynamic stability, 
so the most crystalline samples tend to present lower sol-
ubilities than those less crystallines. Thus, samples such as 
sample 3 (less crystallines than sample 1) which consist in a 
mixture of HA and b-TCP (60:40), show faster initial dissolu-
tion rates, achieving the higher pH value and calcium con-
centration within the first 24 hours of immersion. As it can be 
seen in Figure 1 A-C, the faster release occurs during the 
first 24 hours of immersion, and the values reached for every 
studied sample are shown in Figure 1 B-D. 
For all the bone substitutes, the increase of the pH value 
that takes place within the first 24 hours represents more 
than a 30% of the total pH increase. This reflects that the 
dissolution of the disk surface occurs almost completely 
during this period. 
Next, the effect of a PFM coating on the bioactivity of a 
commercial hydroxyapatite (Plasma Biotal Ltd.) disk is an-
alyzed when soaked into both SBF and a-minimum es-
sential media (a-MEM). The latter contains proteins and 
vitamins and provides a more realistic insight of what 
would occur in the human body. To do so, the HA disks 
were immersed in the interest solutions during 28 days at 
37ºC. To avoid calcite (CaCO
3 ) formation, the medium was 
changed every two days.
As it can be seen in Figure 3, both SBF and a-MEM allow 
for precipitate formation on the HA surface. The precipitate 
distribution lacks of homogeneity in all samples, as crystal 
growth seems to be localized at some points. The latter gives 
evidence of a mechanism of heterogeneous nucleation, 
which was expected, as the beginning of apatite formation 
on calcium phosphate ceramics from SBF solution is usually 
considered as a process of heterogeneous nucleation18, 19.
Figure 3. SEM images of Hydroxyapatite discs af-
ter 28 days soaked both in a-MEM and SBF
Moreover, it can be seen how the PFM coating doesn’t 
block the precipitation events, but instead it seems to 
provide nucleation points which help the precipitate 
formation. As said before, the PFM contains a high-
ly reactive ester group which is able to react with the 
amino acids present in the a-MEM solution, thus the 
anchorage of some amino acids to the PFM coating 
will provide the nucleation points and trigger hetero-
geneous nucleation. By comparing Figure 3B and F, 
it can be clearly appreciated that for the PFM-coated 
disk the formed crystals are bigger and precipitation is 
more extended.
As for the influence of the soaking solution, differences 
are more evident for the PFM coated samples. It can be 
seen how when the sample is soaked into SBF, more 
crystals are formed over the entire surface. This may 
suggest that the amino acids present in the a-MEM, at-
tach covalently to the PFM coating through their amino 
groups and thus, block the nucleation sites which help 
the precipitation of calcium phosphate salts. It seems 
that amino acids play an important role in hydroxyapa-
tite precipitation, and different studies reveal how they 
can play both inhibitory and enhancing effect 20,21. How-
ever, with this assay we have proved the ability of a 
PFM coating to interact with physiologic medium and 
to improve salt deposition. 
The evaluation of the bioactivity of the different sam-
ples has provided insight on the design of a bioceramic 
suitable for bone grafting. Future work is required to 
assess effect of the resorption rate over cell growth and 
tissue formation. 
CONCLUSIONS
The comparative study of the ionic exchange ability of 
different commercial bioceramic bone substitutes and 
medical grade titanium disks has been performed. Mo-
reover, the effect of a PFM coating over the ionic ex-
change ability of a commercial hydroxyapatite has been 
evaluated:
As for the bioceramic bone substitutes the obtained re-
sults show how both the chemical composition and the 
degree of crystallinity have a great influence over the 
interaction ability of the samples with the surrounding 
medium. In spite of the higher solubility of the b-TCP 
with respect to HA, the samples composed by a mixture 
of b-TCP and HA presented a higher ease of interaction 
than those composed of pure b-TCP. As the latter pres-
ents a higher degree of crystallinity, the initial surface 
dissolution needed to trigger the ionic exchange events 
occurs with greater difficulty. Thus, the changes in a 
bioceramic integration ability can be achieved by modi-
fying the b-TCP/HA ratio to achieve the desired effect.
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